CLBX — Cellbxhealth Cashflow Statement
0.000.00%
Last trade - 00:00- £17.38m
- £15.77m
- £2.86m
Annual cashflow statement for Cellbxhealth, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -17.4 | -24.4 | -21.6 | -15 | -19.4 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.29 | 4.1 | 3 | 0.694 | 2.83 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.579 | 2.24 | 1.87 | -0.736 | 3.92 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -14 | -16.1 | -14.5 | -13.4 | -9.26 |
| Capital Expenditures | -1.79 | -1.89 | -0.66 | -0.444 | -0.249 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 16.6 | 0.136 | 0.457 | 0.396 | 0.126 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 14.8 | -1.75 | -0.203 | -0.048 | -0.123 |
| Financing Cash Flow Items | -0.085 | -0.135 | -0.18 | -0.158 | -0.263 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 19 | 18.1 | -1.13 | 7.67 | 6.29 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 19.8 | 0.057 | -15.7 | -5.79 | -3.08 |